Toggle Nav

Thalidomide

In stock
Catalog No.
A4216
Immunomodulatory agent,sedative drug,angiogenesis inhibitor
Grouped product items
SizePriceStock Qty
10mM (in 1mL DMSO)
$60.00
In stock
200mg
$55.00
In stock

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Thalidomide was introduced as a sedative drug,immunomodulatory agent and also is investigated for treating symptoms of many cancers.Thalidomide inhibits an E3 ubiquitin ligase, which is a CRBN-DDB1-Cul4A complex.

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt258.23
Cas No.50-35-1
FormulaC13H10N2O4
Solubility≥11.8 mg/mL in DMSO, <2.53 mg/mL in EtOH, <2.37 mg/mL in H2O
Chemical Name2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
SDFDownload SDF
Canonical SMILESC1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
Shipping ConditionEvaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

Protocol

Cell experiment [1]:

Cell lines

PBMCs

Preparation method

The solubility of this compound in DMSO is > 11.8 mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below - 20 °C for several months.

Reacting condition

0 ~ 100 μg/mL

Applications

Thalidomide dose-dependently increased the proliferative responses of PBMCs stimulated by immobilized anti-CD3. As the concentration of anti-CD3 increased, Thalidomide at a constant concentration of 10 μg/mL significantly induced the proliferative responses of PBMCs. However, Thalidomide exhibited no effect on the proliferative response in the absence of anti-CD3. These results indicated that Thalidomide was not mitogenic, Instead, it acted as a costimulator.

Animal experiment [2]:

Animal models

Rabbits

Dosage form

200 mg/kg; p.o.

Applications

In rabbits, Thalidomide at the dose of 200 mg/kg inhibited the area of vascularized cornea, with a median inhibition of 36%. The inhibition of Thalidomide on angiogenesis was seen after only two doses. In addition, the rabbits did not show significant sedation, and there were no signs of toxicity or weight loss.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Haslett PA, Corral LG, Albert M, Kaplan G. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med. 1998 Jun 1;187(11):1885-92.

[2]. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4082-5.

Quality Control